Ultrasound imaging to predict kidney function after surgery for kidney cancer
Studies whether special ultrasound scans predict kidney recovery in adults having kidney cancer surgery.
Key facts
- Who runs it
- Jinling Hospital, China
- Where
- Nanjing, ChinaSee the site
- Trial code
- Registry title
- Contrast-enhanced Ultrasound and Super-resolution Imaging Predict Renal Function Outcome After Nephrectomy
- Status
- Recruiting
- People taking part
- 285 people, planned
- Started
- 1 Sept 2025
- Expected to end
- 1 Dec 2027
- Type of study
- Observational, 2 groups
- Record updated
- 19 December 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with kidney cancer who are about to have part or all of one kidney removed. It uses special ultrasound scans to study how the kidneys recover.
- Age
- Over 18 years
- Sex
- All sexes
- Disease stage
- Kidney cancer (renal cell carcinoma) with a planned partial or radical nephrectomy. No lymph node spread, distant spread or tumor clot in a vein.
- Earlier treatment
- No radiotherapy, ablation or other surgery on the healthy kidney. No earlier kidney surgery.
- Biomarker or test result
- Kidney function (eGFR) above 45 ml/min/1.73m2 before surgery. ECOG score 0-2.
Main reasons for not taking part
- Only one kidney, or severe weakness of the other kidney (eGFR below 15 ml/min/1.73m2)
- On dialysis or other kidney replacement therapy before surgery
- Allergy to ultrasound contrast agents or other reasons that rule out contrast ultrasound
- Unstable blood circulation or active bleeding
- Other illness limiting life expectancy to under six months
The registry criteria, word for word
Show all 17 criteriaShow less
Who can take part
- Fully understood and voluntarily signed the informed Consent Form (ICF)
- Age: > 18 (at the time of signing the informed consent form); Gender is not limited
- Preoperative eGFR > 45ml/min/1.73m2 (corrected CKD-EPI formula)
- After the clinician formulates the treatment plan and communicates with the patient, they decide whether to perform radical nephrectomy or partial nephrectomy
- ECOG score: 0-2 points
- Be willing and able to abide by the visits, treatments, laboratory tests and other procedures of the research plan
Who cannot take part
- Preoperative reliance on renal replacement therapy (such as dialysis, etc.)
- The healthy kidney has undergone radiotherapy, ablation or other surgeries
- Accompanied by structural abnormalities of the urinary system or functional abnormalities that cannot be corrected in a short time (such as duplicate kidneys, polycystic kidneys, horseshoe kidneys, isolated kidneys, renal artery stenosis > 50%, urinary tract obstruction, and previous history of kidney surgery, etc.), long-term indwelling of urinary catheters, etc
- Previous (≤30 days before randomization) or concurrent participation in another clinical study
- Have a history of allergy to ultrasound contrast agents
- Have any contraindications for contrast-enhanced ultrasound, such as right-to-left shunt, severe pulmonary hypertension, etc
- There are other diseases that limit life expectancy to less than six months
- Patients with solitary kidney or severe contralateral renal insufficiency (eGFR < 15ml/min/1.73m2)
- Patients with hemodynamic instability, including those with persistent hypotension (blood pressure < 90/60 MMHG), uncontrollable heart failure, active bleeding (such as gastrointestinal and cerebral hemorrhage, etc.), or those with a bleeding tendency and hemoglobin < 60g/L and/or platelet count < 50×109/L
- Those who fail to complete the nephrectomy as planned during the operation
- Patients with lymph node metastasis, distant metastasis or venous tumor thrombus
Where in China
- Jinling Hospital, Affiliated Hospital of Medical School, Nanjing UniversityNanjing, ChinaContact: Le QuTaking people
About the trial
What the trial wants to find out
The goal of this prospective cohort study is to evaluate the predictive value of Contrast-Enhanced Ultrasound (CEUS) and Super-Resolution Imaging (SRI) technologies regarding renal function outcomes in patients with renal cell carcinoma (RCC) undergoing partial or radical nephrectomy. The main questions it aims to answer are:
Read full original descriptionShow less
Can quantitative parameters of renal microcirculation and microvascular structure derived from CEUS and SRI predict long-term renal function (defined as New Baseline eGFR for radical nephrectomy and Recovery from Ischemia for partial nephrectomy)? Can these imaging parameters accurately predict the occurrence, severity, and early recovery of postoperative acute kidney injury (AKI)? Researchers will monitor the dynamic evolution of renal blood flow and microvascular density by comparing the affected kidney to the contralateral healthy kidney before and after surgery to see if these biomarkers correlate with clinical outcomes.
Participants will:
Undergo CEUS and SRI examinations before surgery and at specific time points after surgery (e.g., within 7 days) to visualize renal microvasculature.
Provide blood and urine samples for standard laboratory tests (such as serum creatinine and Cystatin C) to assess kidney function during hospitalization.
Attend follow-up visits at 1, 3, 6, 9, and 12 months post-surgery to monitor long-term renal recovery and complete necessary imaging assessments (CT or Ultrasound).
The 2 groups in the trial
- Patients scheduled for radical nephrectomy
- Patients scheduled for partial nephrectomy
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- A Prospective Clinical Study on the Predictive Value of CEUS and Super-resolution Imaging Technology for Renal Function Outcome in Patients After Partial or Radical Nephrectomy
- Plain-language title
- Ultrasound imaging to predict kidney function after surgery for kidney cancerGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 13 November 2026.
- Record updated
- 19 December 2025